Guggenheim analyst John Difucci downgrades Workday (NASDAQ:WDAY) from Neutral to Sell.
Clovis Oncology Shares Nose-Dive As Potential Bankruptcy Filing Looms
Clovis Oncology Inc (NASDAQ: CLVS) posted a Q3 EPS loss of $(0.39), up from $(0.56) a year ago, on sales of $30.66 million, down from $37.92 million.